Fluorophotometric measurement of the precorneal residence time of topically applied hyaluronic acid

British Journal of Ophthalmology

Volumn 92, Issue 1, 2008, Pages 108-111

  Mochizuki, H ^a   Yamada, M ^a   Hato, S ^a   Nishida, T ^b  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN HYALURONIC ACID; FLUORESCEIN SODIUM; FLUORESCENT DYE; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; EYE DROPS; FLUORESCEIN;

ADULT; AQUEOUS HUMOR FLOW; ARTICLE; CORNEA; FEMALE; FLUOROPHOTOMETRY; HUMAN; MALE; NORMAL HUMAN; PLOTS AND CURVES; PRIORITY JOURNAL; RANK SUM TEST; STATISTICAL SIGNIFICANCE; VOLUNTEER; DRUG EFFECT; LACRIMAL FLUID; METABOLISM; METHODOLOGY;

ADULT; FEMALE; FLUORESCEIN; FLUOROPHOTOMETRY; HUMANS; HYALURONIC ACID; MALE; OPHTHALMIC SOLUTIONS; TEARS;

EID: 38349115057     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.121533     Document Type: Article

References (26)

1. Johnson ME, Murphy PJ. Changes in the tear film and ocular surface from dry eye syndrome. Prog Retin Eye Res 2004;23:449-74.
2. Holy FJ, Lemp MA. Tear physiology and dry eyes. Surv Ophthalmol 1977;22:69-87
3. Lemp MA. Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J 1995;21:221-32.
4. Nelson JD, Farris RL. Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. Arch Ophthalmol 1988;106:484-7.
5. Polack FM, McNiece MT. The treatment of dry eyes with Na hyaluronate (Healon): a preliminary report. Cornea 1982;1:133-6.
6. Stuart JC, Linn JG. Dilute sodium hyaluronate (Healon) in the treatment of ocular surface disorders. Ann Ophthalmol 1985;17:190-2.
7. DeLuise VP, Peterson WS. The use of topical Healon tears in the management of refractory dry-eye syndrome. Ann Ophthalmol 1984;16:823-4.
8. Aragona P, Papa V, Micali A, et al. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 2002;86:181-4.
9. Limberg MB, McCaa C, Kissling GE, et al. Topical application of hyaluronic acid and chondroitin sulfate in the treatment of dry eyes. Am J Ophthalmol 1987;103:194-7.
10. Shimmura S, Ono M, Shinozaki K, et al. Sodium hyaluronate eye drops in the treatment of dry eyes. Br J Ophthalmol 1995;70:1007-11.
11. Condon PI, McEwen CG, Wright M, et al. Double blind, randomized, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome. Br J Ophthalmol 1999;83:1121-4.
12. Nakamura S, Okada S, Umeda Y, et al. Development of a rabbit model of tear film instability and evaluation of viscosity of artificial tear preparations. Cornea 2004;23:390-7.
13. Nakamura M, Hikida M, Nakano T, et al. Characterization of water retentive properties of hyaluronan. Cornea 1993;12:433-6.
14. Nishida T, Nakamura M, Mishima H, et al. Hyaluronan stimulates corneal epithelial migration. Exp Eye Res 1991;53:753- 8.
15. Sugiyama T, Miyauchi S, Machida A, et al. The effect of sodium hyaluronate on the migration of rabbit corneal epithelium. The effect of topical administration. J Ocular Pharmacol 1991;7:53-64.
16. Gomes JAP, Amankwah R, Powell-Richards A, et al. Sodium hyaluronate promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol 2004;88:821-5.
17. Watanabe T, Kawashima M, Kawai M, et al. Effect of sodium hyaluronate eyedrops on tear meniscus height determined by fluorescein photography. [in Japanese] Folia Ophthalmol Jpn 2004;55:369-73.
18. Tsubota K, Yamada M. Tear evaporation from the ocular surface. Invest Ophthalmol Vis Sci 1992;33:2942-50.
19. Mengher LS, Pandher KS, Bron AJ, et al. The effect of sodium hyaluronate (0.1%) on break-up time (NIBUT) in patients with dry eyes. Br J Ophthalmol 1986;70:442-7.
20. Hamano T, Horimoto K, Lee M, et al. Evaluation of the effect of sodium hyaluronate ophthalmic solution on tear film stability. [in Japanese] J Jpn Ophthalmol Soc 1993;97:928-32.
21. Johnson ME, Murphy PJ, Boulton M. Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye. Graefes Arch Clin Exp Ophthalmol 2006;244:109-12.
22. Snibson GR, Greaves JL, Soper NDW, et al. Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy. Eye 1990;4:594-602.
23. Gurny R, Ryser JE, Tabatabay C, et al. Precorneal residence time in humans of sodium hyaluronate as measured by gamma scintigraphy. Graefes Arch Clin Exp Ophthalmol 1990;228:510-2
24. Snibson GR, Greaves JL, Soper NDW, et al. Ocular surface residence times of artificial tear solutions. Cornea 1992;11:288- 93.
25. Mishima S, Gasset A, Klyce Jr SD, et al. Determination of tear volume and tear flow. Invest Ophthalmol Vis Sci 1966;5:264- 76.
26. Asari A, Morita M, Sekiguchi T, et al. Hyaluronan, CD44 and fibronectin in rabbit corneal wound healing. Jpn J Ophthalmol 1996;40:18-25.